AAAAAA

   
Results: 1-11 |
Results: 11
Moxifloxacin: Clinical efficacy and safety
Authors: Culley, CM Lacy, MK Klutman, N Edwards, B
Citation: Cm. Culley et al., Moxifloxacin: Clinical efficacy and safety, AM J HEAL S, 58(5), 2001, pp. 379-388
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
Authors: Nicolau, DP McNabb, J Lacy, MK Quintiliani, R Nightingale, CH
Citation: Dp. Nicolau et al., Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia, INT J ANT A, 17(6), 2001, pp. 497-504
Randomized, crossover adherence trial of azithromycin and clarithromycin for Mycobacterium avium complex prophylaxis in AIDS patients
Authors: McNabb, J Lacy, MK Ross, JW Rousseau, M Nightingale, CH Nicolau, DP
Citation: J. Mcnabb et al., Randomized, crossover adherence trial of azithromycin and clarithromycin for Mycobacterium avium complex prophylaxis in AIDS patients, INF DIS C P, 9(1), 2000, pp. 27-32
Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci
Authors: Lacy, MK Tessier, PR Nicolau, DP Nightingale, CH Quintiliani, R
Citation: Mk. Lacy et al., Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci, INT J ANT A, 15(1), 2000, pp. 25-30
Pharmacokinetics and pharmacodynamics of continuous and intermittent ceftazidime during the treatment of nosocomial pneumonia
Authors: Nicolau, DP McNabb, JC Lacy, MK Li, J Quintiliani, R Nightingale, CH
Citation: Dp. Nicolau et al., Pharmacokinetics and pharmacodynamics of continuous and intermittent ceftazidime during the treatment of nosocomial pneumonia, CLIN DRUG I, 18(2), 1999, pp. 133-139
Pharmacokinetics of continuous and intermittent ceftazidime in intensive care unit patients with nosocomial pneumonia
Authors: Nicolau, DP Lacy, MK McNabb, JC Quintiliani, R Nightingale, CH
Citation: Dp. Nicolau et al., Pharmacokinetics of continuous and intermittent ceftazidime in intensive care unit patients with nosocomial pneumonia, INF DIS C P, 8(1), 1999, pp. 45-49
Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials
Authors: Lamp, KC Freeman, CD Klutmam, NE Lacy, MK
Citation: Kc. Lamp et al., Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials, CLIN PHARMA, 36(5), 1999, pp. 353-373
Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model
Authors: Lacy, MK Nicolau, DP Banevicius, MA Nightingale, CH Quintiliani, R
Citation: Mk. Lacy et al., Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model, J ANTIMICRO, 44(4), 1999, pp. 477-481
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillinagainst Streptococcus pneumoniae in an in vitro model of infection
Authors: Lacy, MK Lu, W Xu, XW Tessier, PR Nicolau, DP Quintiliani, R Nightingale, CH
Citation: Mk. Lacy et al., Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillinagainst Streptococcus pneumoniae in an in vitro model of infection, ANTIM AG CH, 43(3), 1999, pp. 672-677
Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS
Authors: Lacy, MK Nicolau, DP Nightingale, CH Geffken, A Teng, RL Vincent, J Quintiliani, R
Citation: Mk. Lacy et al., Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS, ANTIM AG CH, 43(12), 1999, pp. 3005-3007
Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae
Authors: Lacy, MK Owens, RC Xu, XW Nicolau, DP Quintiliani, R Nightingale, CH
Citation: Mk. Lacy et al., Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae, INT J ANT A, 10(4), 1998, pp. 279-283
Risultati: 1-11 |